Skip to main content
Fig. 4 | World Journal of Surgical Oncology

Fig. 4

From: Survival outcomes of adjuvant taxanes, platinum plus fluoropyrimidines versus platinum and fluoropyrimidines for gastric cancer patients after D2 gastrectomy: a retrospective propensity score-matched analysis

Fig. 4

Forest plot of hazard ratios and 95% confidence intervals for disease-free survival by characteristics of patients. PF, platinum plus fluoropyrimidines; TPF, taxanes, platinum plus fluoropyrimidines; AJCC, American Joint Committee on Cancer; HR, hazard ratio; 95% CI, 95% confidence interval

Back to article page